𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of low dose tacrolimus, mycophenolate mofetil and maintenance IL-2 receptor blockade in an islet transplant recipient

✍ Scribed by B. Kaplan; P. West; H. Neeley; J. Martellotto; R. Iqbal; A. Gangemi; B. Hatipoglu; E. Benedetti; J. Oberholzer

Book ID
110889908
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
158 KB
Volume
22
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Evaluation of renal function in liver tr
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n